| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0076 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |